{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:21:12Z","timestamp":1790835672201,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015872","name":"University of Lille","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015872","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Groupe Francophone de Recherche sur la Scl\u00e9rodermie (GFRS)"},{"name":"Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI)"},{"name":"Association des Scl\u00e9rodermiques de France (ASF)"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"crossref","award":["2012-000770-36"],"award-info":[{"award-number":["2012-000770-36"]}],"id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Binding Site"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.autrev.2017.10.015","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T20:44:29Z","timestamp":1516135469000},"page":"244-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Altered B lymphocyte homeostasis and functions in systemic sclerosis"],"prefix":"10.1016","volume":"17","author":[{"given":"Alexandra","family":"Forestier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Guerrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Jouvray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Giovannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Lef\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Sobanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Hauspie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Hatron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Z\u00e9phir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Vermersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Labalette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Launay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Dubucquoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.autrev.2017.10.015_bb0005","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","article-title":"T cells in systemic sclerosis: a reappraisal","volume":"51","author":"O'Reilly","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.10.015_bb0010","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/rheumatology\/keg170","article-title":"The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis","volume":"42","author":"Hesselstrand","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.10.015_bb0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/art.38219","article-title":"Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: new data from a French cohort and a systematic review and meta-analysis","volume":"66","author":"Sobanski","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2230.2007.02678.x","article-title":"Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody","volume":"33","author":"Komura","year":"2008","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0025","first-page":"389","article-title":"The role of B cells in systemic sclerosis","volume":"2","author":"Kraaij","year":"2008","journal-title":"Biol Targets Ther"},{"key":"10.1016\/j.autrev.2017.10.015_bb0030","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/annrheumdis-2013-204522","article-title":"Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group","volume":"74","author":"Jordan","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2017.10.015_bb0035","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.autrev.2015.07.008","article-title":"Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature","volume":"14","author":"Giuggioli","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2017.10.015_bb0040","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/art.40016","article-title":"Scleroderma peripheral B lymphocytes secrete interleukin-6 and TGF-\u03b2 and activate fibroblasts","volume":"69","author":"Dumoitier","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2015.10.005","article-title":"Systemic sclerosis: new evidence re-enforces the role of B cells","volume":"15","author":"Sakkas","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2017.10.015_bb0050","first-page":"496","article-title":"Systemic sclerosis patients present alterations in the expression of molecules involved in B-cell regulation","author":"Soto","year":"2015","journal-title":"Immunol Toler"},{"key":"10.1016\/j.autrev.2017.10.015_bb0055","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.autrev.2011.04.013","article-title":"B cells in systemic sclerosis: a possible target for therapy","volume":"10","author":"Bosello","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2017.10.015_bb0060","doi-asserted-by":"crossref","first-page":"R168","DOI":"10.1186\/ar4352","article-title":"B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis","volume":"15","author":"Fran\u00e7ois","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2017.10.015_bb0065","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1002\/cyto.b.20547","article-title":"Human peripheral blood B-cell compartments: a crossroad in B-cell traffic","volume":"78","author":"Perez-Andres","year":"2010","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.autrev.2017.10.015_bb0070","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/art.20274","article-title":"Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells","volume":"50","author":"Sato","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2017.10.015_bb0075","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar3907","article-title":"IL-10-producing regulatory B cells (B10 cells) in autoimmune disease","volume":"15","author":"Kalampokis","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.autrev.2017.10.015_bb0080","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4049\/jimmunol.1401329","article-title":"B10 cells: a functionally defined regulatory B cell subset","volume":"194","author":"Tedder","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0085","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4049\/jimmunol.176.2.705","article-title":"A case for regulatory B cells","volume":"176","author":"Mizoguchi","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0090","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2017.10.015_bb0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","article-title":"Immune regulatory function of B cells","volume":"30","author":"Mauri","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-60761-869-0_7","article-title":"Identifying regulatory B cells (B10 cells) that produce IL-10 in mice","volume":"677","author":"Matsushita","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2017.10.015_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049835","article-title":"Decrease in proportion of CD19+ CD24(hi) CD27+ B cells and impairment of their suppressive function in Graves' disease","volume":"7","author":"Zha","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2017.10.015_bb0120","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1182\/blood-2014-04-571125","article-title":"Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD","volume":"124","author":"Khoder","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2017.10.015_bb0125","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/art.38666","article-title":"Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity","volume":"66","author":"Daien","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0130","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1002\/art.38742","article-title":"Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus","volume":"66","author":"Gao","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/rheumatology\/kev331","article-title":"Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity","volume":"55","author":"Matsushita","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2017.10.015_bb0140","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/art.39437","article-title":"Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis","volume":"68","author":"Mavropoulos","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0145","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s11926-015-0506-3","article-title":"New ACR EULAR guidelines for systemic sclerosis classification","volume":"17","author":"Johnson","year":"2015","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.autrev.2017.10.015_bb0150","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"EC","year":"1988","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0155","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1183\/09031936.05.00034905","article-title":"Standardisation of the single-breath determination of carbon monoxide uptake in the lung","volume":"26","author":"Macintyre","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.autrev.2017.10.015_bb0160","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1183\/09031936.05.00035005","article-title":"Standardisation of the measurement of lung volumes","volume":"26","author":"Wanger","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.autrev.2017.10.015_bb0165","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.autrev.2017.10.015_bb0170","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.4049\/jimmunol.1201807","article-title":"Identification of B cell defects using age-defined reference ranges for in vivo and in vitro B cell differentiation","volume":"190","author":"Aan de Kerk","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0175","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/eji.201344341","article-title":"TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells","volume":"44","author":"Liu","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0180","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.4049\/jimmunol.165.3.1612","article-title":"Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression","volume":"165","author":"Benkhart","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0185","doi-asserted-by":"crossref","first-page":"310ra166","DOI":"10.1126\/scitranslmed.aab4176","article-title":"Proinflammatory GM-CSF\u2013producing B cells in multiple sclerosis and B cell depletion therapy","volume":"7","author":"Li","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"Suppl. 100","key":"10.1016\/j.autrev.2017.10.015_bb0190","first-page":"30","article-title":"Reduced non-switched memory B cell subsets cause imbalance in B cell repertoire in systemic sclerosis","volume":"34","author":"Simon","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/jaut.2000.0363","article-title":"B cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis: roles of B cell CD95, CD95L and Bcl-2 expression","volume":"14","author":"White","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.autrev.2017.10.015_bb0200","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0952-7915(98)80222-7","article-title":"Mechanisms of CD95 (APO-1\/Fas)-mediated apoptosis","volume":"10","author":"Peter","year":"1998","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0205","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1002\/art.38023","article-title":"CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis","volume":"65","author":"Sellam","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2017.10.015_bb0210","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1164\/rccm.200807-1089OC","article-title":"Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3","volume":"179","author":"Kelsen","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.autrev.2017.10.015_bb0215","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.4049\/jimmunol.1102639","article-title":"The skin, a novel niche for recirculating B cells","volume":"188","author":"Geherin","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0220","doi-asserted-by":"crossref","first-page":"R18","DOI":"10.1186\/ar3242","article-title":"Dysregulated expression of MIG\/CXCL9, IP-10\/CXCL10 and CXCL16 and their receptors in systemic sclerosis","volume":"13","author":"Rabquer","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.autrev.2017.10.015_bb0225","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1684\/ejd.2011.1469","article-title":"Up-regulation of CC chemokine ligand 20 and its receptor CCR6 in the lesional skin of early systemic sclerosis","volume":"21","author":"Tao","year":"2011","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0230","article-title":"Cytokine-mediated regulation of plasma cell generation: IL-21 takes center stage","volume":"5","author":"Tangye","year":"2014","journal-title":"B Cell Biol"},{"key":"10.1016\/j.autrev.2017.10.015_bb0235","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/art.38734","article-title":"Primary Sj\u00f6gren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells","volume":"66","author":"Roberts","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0240","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/ar3042","article-title":"Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients","volume":"12","author":"Rodr\u00edguez-Bayona","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.autrev.2017.10.015_bb0245","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1073\/pnas.0901984106","article-title":"Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells","volume":"106","author":"Rakhmanov","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.autrev.2017.10.015_bb0250","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/art.37828","article-title":"Expansion of autoreactive unresponsive CD21(-\/low) B cells in Sj\u00f6gren's syndrome associated lymphoproliferation","volume":"65","author":"Saadoun","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2017.10.015_bb0255","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","article-title":"Complement receptor 2\/CD21\u2212 human naive B cells contain mostly autoreactive unresponsive clones","volume":"115","author":"Isnardi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2017.10.015_bb0260","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/ni1054","article-title":"Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation","volume":"5","author":"Ma","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0265","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.autrev.2014.07.003","article-title":"Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity","volume":"13","author":"Lanteri","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2017.10.015_bb0270","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaut.2012.05.012","article-title":"TLR9 drives the development of transitional B cells towards the marginal zone pathway and promotes autoimmunity","volume":"39","author":"Guerrier","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.autrev.2017.10.015_bb0275","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/intimm\/dxl047","article-title":"Spontaneous B cell hyperactivity in autoimmune-prone MRL mice","volume":"18","author":"Nijnik","year":"2006","journal-title":"Int. Immunol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0280","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.4049\/jimmunol.164.10.5000","article-title":"Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB\/NZW mice","volume":"164","author":"Zeng","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0285","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.21526","article-title":"Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes","volume":"54","author":"Matsushita","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2017.10.015_bb0290","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2567.2006.02331.x","article-title":"Phenotypic and functional characterization of human CD25+ B cells","volume":"117","author":"Brisslert","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2017.10.015_bb0295","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-3083.2006.01889.x","article-title":"CD25-expressing B-lymphocytes in Rheumatic Diseases","volume":"65","author":"Amu","year":"2007","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0300","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3899\/jrheum.100074","article-title":"B cell abnormalities in Wegener's granulomatosis and microscopic polyangiitis: role of CD25+-expressing B cells","volume":"37","author":"Eriksson","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0305","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-065X.2008.00661.x","article-title":"Regulatory B cells as inhibitors of immune responses and inflammation","volume":"224","author":"Bouaziz","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.autrev.2017.10.015_bb0310","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-016-1213-9","article-title":"TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients","volume":"19","author":"Aravena","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.autrev.2017.10.015_bb0320","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2012-11-465658","article-title":"Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease","author":"Le Huu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2017.10.015_bb0325","article-title":"Amelioration of autoimmune arthritis by adoptive transfer of Foxp3-expressing regulatory B cells is associated with the Treg\/Th17 cell balance","volume":"14","author":"Park","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.autrev.2017.10.015_bb0330","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nrrheum.2014.95","article-title":"Autoimmunity: regulatory B cells\u2014IL-35 and IL-21 regulate the regulators","volume":"10","author":"Tedder","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0335","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/eji.201343994","article-title":"Ca(2+)-related signaling events influence TLR9-induced IL-10 secretion in human B cells","volume":"44","author":"Ziegler","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0340","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.44","article-title":"IL10 inhibits starvation-induced autophagy in hypertrophic scar fibroblasts via cross talk between the IL10-IL10R-STAT3 and IL10-AKT-mTOR pathways","volume":"7","author":"Shi","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.autrev.2017.10.015_bb0345","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1126\/science.aal3535","article-title":"Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages","volume":"356","author":"Ip","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.autrev.2017.10.015_bb0350","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/721608","article-title":"The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis","volume":"2011","author":"Barnes","year":"2011","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.autrev.2017.10.015_bb0355","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.2147\/DDDT.S99696","article-title":"Spotlight on tocilizumab and its potential in the treatment of systemic sclerosis","volume":"10","author":"Sakkas","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.autrev.2017.10.015_bb0360","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3899\/jrheum.120725","article-title":"Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis","volume":"40","author":"De Lauretis","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.autrev.2017.10.015_bb0365","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","article-title":"Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis","volume":"71","author":"Khan","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2017.10.015_bb0370","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2249.2004.02642.x","article-title":"Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement","volume":"138","author":"Scala","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.autrev.2017.10.015_bb0375","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1164\/ajrccm.149.5.8173768","article-title":"Interleukin 6 secretion by monocytes and alveolar macrophages in systemic sclerosis with lung involvement","volume":"149","author":"Crestani","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218300077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218300077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T14:23:16Z","timestamp":1603635796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218300077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1568997218300077"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2017.10.015","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered B lymphocyte homeostasis and functions in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2017.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}